Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing two types of electrodes for treating lower back pain from lumbar spondylosis

Official title: Efficacy of Radiofrequency Ablation Using Multi-Tined Electrodes vs. Traditional Electrodes for Treatment of Lumbar Spondylosis

Run by University of Arkansas · NCT06477094 · Data updated 2026-11-12

This study is testing two different types of electrodes to see which one helps people with lower back pain from lumbar spondylosis feel better.

More Lumbar Spondylosis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment25 (estimated)
SponsorUniversity of Arkansas
Academic / other
Drugs / interventionsradiation
Locations1 site (Little Rock, Arkansas)
StatusRecruiting
StartedAugust 9, 2024
Main results expectedJuly 31, 2027
Study endsSeptember 30, 2027
Registry record updatedSeptember 10, 2026
Trial IDNCT06477094 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with chronic non-radicular lower back pain who have not responded to conservative treatments.

Probably not a fit

Patients with a history of coagulopathy, significant comorbidities, or previous lumbar RFA attempts may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of two different radiofrequency ablation (RFA) techniques for patients suffering from lumbar spondylosis, a common cause of lower back pain. Participants will be randomly assigned to receive treatment using either the Stratus Nimbus multi-tined electrode or the Stryker Venom electrode. The study aims to assess pain relief and functional improvement after the procedures, with patients undergoing a thorough evaluation to ensure they meet the necessary criteria for candidacy. The trial is conducted at the University of Arkansas for Medical Sciences and employs a double-blinded approach to ensure unbiased results.

Why it matters

Potential benefit: If successful, this study could provide a more effective treatment option for patients suffering from chronic lower back pain due to lumbar spondylosis.

How similar studies have gone: Previous studies have shown promising results with radiofrequency ablation techniques, but this specific comparison of electrode types is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Greater than 18 years of age
2. Presenting with chronic non-radicular lower back pain
3. Failure of conservative treatment such as physical therapy or NSAID usage
4. Diagnosis of lumbar facet mediated lower back pain by a board-certified chronic pain physician via two sets of prognostic lumbar MBBs with 0.5cc of 0.5% bupivacaine with \>80% pain relief

Exclusion Criteria:

1. History of known coagulopathy
2. \> 3 American Society of Anesthesiologists Classification
3. Pregnancy
4. Spinal hardware between L3 and S1
5. Allergies to injection medications
6. English illiteracy
7. Pain improvement following physical therapy or NSAID usage
8. Previous history of attempted lumbar RFA

Where it's running

  • University of Arkansas for Medical Sciences
    Little Rock, Arkansas, United States
    Recruiting

Study contacts

  • Principal investigator: Aparna Jindal, MD — University of Arkansas
  • Study coordinator: Edward Denton, MD
  • Email: edenton@uams.edu
  • Phone: 9018323377

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.